Wealth Alliance LLC Sells 1,108 Shares of UnitedHealth Group Incorporated $UNH

Wealth Alliance LLC decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 21.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,058 shares of the healthcare conglomerate’s stock after selling 1,108 shares during the quarter. Wealth Alliance LLC’s holdings in UnitedHealth Group were worth $1,266,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in UNH. Nuveen LLC bought a new position in UnitedHealth Group during the first quarter worth about $3,846,764,000. Vanguard Group Inc. lifted its position in UnitedHealth Group by 6.6% during the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock valued at $47,519,620,000 after purchasing an additional 5,583,343 shares during the period. Wellington Management Group LLP lifted its holdings in UnitedHealth Group by 10.6% during the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock valued at $13,537,859,000 after purchasing an additional 2,486,839 shares in the last quarter. National Bank of Canada FI grew its stake in shares of UnitedHealth Group by 137.8% in the 1st quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate’s stock worth $859,518,000 after buying an additional 950,928 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in UnitedHealth Group by 13.6% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock valued at $3,702,736,000 after purchasing an additional 847,054 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.3%

UnitedHealth Group stock traded down $1.10 during trading hours on Thursday, reaching $337.96. The company had a trading volume of 1,354,404 shares, compared to its average volume of 12,234,899. The firm has a market cap of $306.14 billion, a price-to-earnings ratio of 17.67, a P/E/G ratio of 2.28 and a beta of 0.47. The company has a 50-day moving average price of $347.08 and a 200 day moving average price of $320.66. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $622.83. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, beating the consensus estimate of $2.87 by $0.05. The company had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. UnitedHealth Group’s quarterly revenue was up 12.2% on a year-over-year basis. During the same period last year, the company posted $7.15 earnings per share. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be paid a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.6%. The ex-dividend date of this dividend is Monday, December 8th. UnitedHealth Group’s payout ratio is currently 46.14%.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of research analyst reports. Mizuho upped their price objective on shares of UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a research report on Thursday, October 9th. Deutsche Bank Aktiengesellschaft downgraded UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price objective for the company. in a report on Wednesday, October 29th. Truist Financial raised their target price on UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research note on Tuesday, September 9th. Wells Fargo & Company raised their price objective on shares of UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a research report on Tuesday, October 7th. Finally, TD Cowen increased their target price on UnitedHealth Group from $335.00 to $338.00 and gave the stock a “hold” rating in a report on Thursday, October 30th. Eighteen research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $397.12.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.